Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Impact of drug policy on the consumption of original and generic antihypertensive drugs

  • At: Seville (Spain) (2022)
  • Type: Poster
  • Poster code: SAP-056
  • By: TRECIOKIENE, Indre (Pharmacy center, Institute of Biomedical Science, Faculty of Medicine, Vilnius University, Lithuania)
  • Co-author(s): Mrs Indre Treciokiene, Researcher (Pharmacy center, Institute of Biomedical Science, Faculty of Medicine, Vilnius University, Vilnius, Lithuania / Department of PharmacoTherapy, -Epidemiology & -Economics, Faculty of Science and Engineering, University of Groningen, Groningen, Netherlands)
    Benedikta Miksiniene (Medicines Policy Division, Ministry of Health of The Republic of Lithuania, Vilnius, Lithuania)
    Jolanta Gulbinovic, Department of Pathology, Forensic Medicine and Pharmacology (Department of Pathology, Forensic Medicine and Pharmacology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania)
    Katja Taxis, Department of PharmacoTherapy, -Epidemiology & -Economics (Department of PharmacoTherapy, -Epidemiology & -Economics, Faculty of Science and Engineering, University of Groningen, Groningen, Netherlands)
  • Abstract:

    Background information
    Rational use of medicines requires that patients receive appropriate medications at the lowest cost to them and their community. Pharmaceutical expenditure is increasing in all European countries. As a consequence, third-party payers have introduced multiple reforms and initiatives in recent years to optimize the managed..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses